Health Care & Life Sciences » Biotechnology | Orexigen Therapeutics Inc.

Orexigen Therapeutics Inc.

Orexigen Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
18.89 M
Public Float
8.37 M

Profile

Address
3344 North Torrey Pines Court
La Jolla California 92037
United States
Employees -
Website http://www.orexigen.com
Updated 09/14/2018
Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities includes recruiting personnel, conducting research and development, including clinical trials, raising capital and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.

Financials

View All
Created with Highcharts 5.0.14Orexigen Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.90 09490 09477 67177 67137 52537 52568 68768 68724 52424 52420122013201420152016020k40k60k80k100k
Created with Highcharts 5.0.14Orexigen Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.3 4283 4283 4283 42855 52155 52124 45924 45933 70933 70920122013201420152016010k20k30k40k50k60k

Lota S. Zoth
Chairman
Lota S. Zoth
Chairman